Suppression of tumor growth through disruption of hypoxia-inducible transcription (original) (raw)

• Semenza, G.L. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu. Rev. Cell. Dev. Biol. 15, 551–578 (1999).
  Article CAS Google Scholar
• Wang, G.L., Jiang, B.H., Rue, E.A. & Semenza, G.L. Hypoxia-inducible factor 1 is a basic-HLH-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. USA 92, 5510–5514 (1995).
  Article CAS Google Scholar
• Salceda, S. & Caro, J. HIF-1α protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J. Biol. Chem. 272, 22642–22647 (1997).
  Article CAS Google Scholar
• Huang, L.E., Arany, Z., Livingston, D.M. & Bunn, H.F. Activation of HIF depends primarily upon redox-sensitive stabilization of its α subunit. J. Biol. Chem. 271, 32253–32259 (1996).
  Article CAS Google Scholar
• Maxwell, P.H. et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271–275 (1999).
  Article CAS Google Scholar
• Cockman, M.E. et al. HIF-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J. Biol. Chem. 275, 25733–25741 (2000).
  Article CAS Google Scholar
• Ohh, M. et al. Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein. Nature Cell Biol. 2, 423–427 (2000).
  Article CAS Google Scholar
• Jiang, B.H., Semenza, G.L., Bauer, C. & Marti, H.H. HIF-1 levels vary exponentially over a physiologically relevant range of O2 tension. Am. J. Physiol. 271, C1172–1180 (1996).
  Article CAS Google Scholar
• Jiang, B.H., Rue, E., Wang, G.L., Roe, R. & Semenza, G.L. Dimerization, DNA binding, and transactivation properties of HIF-1. J. Biol. Chem. 271, 17771–17778 (1996).
  Article CAS Google Scholar
• Arany, Z. et al. An essential role for p300/CBP in the cellular response to hypoxia. Proc. Natl. Acad. Sci. USA 93, 12969–12973 (1996).
  Article CAS Google Scholar
• Ebert, B.L. & Bunn, H.F. Regulation of transcription by hypoxia requires a multiprotein complex that includes HIF-1, an adjacent transcription factor, and p300/CREB binding protein. Mol. Cell. Biol. 18, 4089–4096 (1998).
  Article CAS Google Scholar
• Kallio, P.J. et al. Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 co-activator by the HIF-1α. EMBO J. 17, 6573–6586 (1998).
  Article CAS Google Scholar
• Carrero, P. et al. Redox-regulated recruitment of the transcriptional co-activators CREB-binding protein and SRC-1 to HIF-1α. Mol. Cell. Biol. 20, 402–415 (2000).
  Article CAS Google Scholar
• Semenza, G.L. & Wang, G.L. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 12, 5447–5454 (1992).
  Article CAS Google Scholar
• Nordsmark, M., Bentzen, S.M. & Overgaard, J. Measurement of human tumour oxygenation status by a polarographic needle electrode. An analysis of inter- and intratumour heterogeneity. Acta Oncol. 33, 383–389 (1994).
  Article CAS Google Scholar
• Helmlinger, G., Yuan, F., Dellian, M. & Jain, R.K. Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nature Med. 3, 177–182 (1997).
  Article CAS Google Scholar
• Brown, J.M. Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies. Mol. Med. Today. 6, 157–162 (2000).
  Article CAS Google Scholar
• Shweiki, D., Itin, A., Soffer, D. & Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843–845 (1992).
  Article CAS Google Scholar
• Zhong, H. et al. Overexpression of HIF-1α in common human cancers and their metastases. Cancer Res. 59, 5830–5835 (1999).
  CAS PubMed Google Scholar
• Hockel, M. et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 56, 4509–4515 (1996).
  CAS PubMed Google Scholar
• Brizel, D.M. et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 56, 941–943 (1996).
  CAS PubMed Google Scholar
• Zeman, E. M., Brown, J. M., Lemmon, M. J., Hirst, V. K. & Lee, W. W. SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells. Int. J. Radiat. Oncol. Biol. Phys. 12, 1239–1242 (1986).
  Article CAS Google Scholar
• Binley, K., Iqball, S., Kingsman, A., Kingsman, S. & Naylor, S. An adenoviral vector regulated by hypoxia for the treatment of ischaemic disease and cancer. Gene Ther. 6, 1721–1727 (1999).
  Article CAS Google Scholar
• Shibata, T., Giaccia, A.J. & Brown, J.M. Development of a hypoxia-responsive vector for tumor-specific gene therapy. Gene Ther. 7, 493–498 (2000).
  Article CAS Google Scholar
• Jiang, B.H., Zheng, J.Z., Leung, S.W., Roe, R. & Semenza, G.L. Transactivation and inhibitory domains of HIF-1α. Modulation of transcriptional activity by oxygen tension. J. Biol. Chem. 272, 19253–19260 (1997).
  Article CAS Google Scholar
• Wilson, I. A. et al. Identical short peptide sequences in unrelated proteins can have different conformations: a testing ground for theories of immune recognition. Proc. Natl. Acad. Sci. USA 82, 5255–5259 (1985).
  Article CAS Google Scholar
• Chakravarti, D. et al. Role of CBP/P300 in nuclear receptor signalling. Nature 383, 99–103 (1996).
  Article CAS Google Scholar
• Oliner, J.D., Andresen, J.M., Hansen, S.K., Zhou, S. & Tjian, R. SREBP transcriptional activity is mediated through an interaction with the CREB-binding protein. Genes Dev. 10, 2903–2911 (1996).
  Article CAS Google Scholar
• Yao, T.P., Ku, G., Zhou, N., Scully, R. & Livingston, D.M. The nuclear hormone receptor co-activator SRC-1 is a specific target of p300. Proc. Natl. Acad. Sci. USA 93, 10626–10631 (1996).
  Article CAS Google Scholar
• Bhattacharya, S. et al. Cooperation of Stat2 and p300/CBP in signalling induced by interferon-α. Nature 383, 344–347 (1996).
  Article CAS Google Scholar
• Carmeliet, P. et al. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394, 485–490 (1998).
  Article CAS Google Scholar
• Ryan, H.E., Lo, J. & Johnson, R.S. HIF-1α is required for solid tumor formation and embryonic vascularization. EMBO J 17, 3005–3015 (1998).
  Article CAS Google Scholar
• Maxwell, P.H. et al. HIF-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc. Natl. Acad. Sci. USA 94, 8104–8109 (1997).
  Article CAS Google Scholar
• Ryan, H.E. et al. HIF-1α is a positive factor in solid tumor growth. Cancer Res. 60, 4010–015 (2000).
  CAS PubMed Google Scholar
• Zhong, H. et al. Modulation of HIF-1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res. 60, 1541–1545 (2000).
  CAS PubMed Google Scholar
• Zundel, W. et al. Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev. 14, 391–396 (2000).
  CAS PubMed PubMed Central Google Scholar
• Jiang, B.H., Rue, E., Wang, G.L., Roe, R. & Semenza, G.L. Dimerization, DNA binding, and transactivation properties of HIF-1. J. Biol. Chem. 271, 17771–17778 (1996).
  Article CAS Google Scholar
• Kamei, Y. et al. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85, 403–414 (1996).
  Article CAS Google Scholar
• Horvai, A.E. et al. Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. Proc. Natl. Acad. Sci. USA 94, 1074–1079 (1997).
  Article CAS Google Scholar
• Foster, B.A., Coffey, H.A., Morin, M.J. & Rastinejad, F. Pharmacological rescue of mutant p53 conformation and function. Science 286, 2507–2510 (1999).
  Article CAS Google Scholar
• Olumi, A.F. et al. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 59, 5002–5011 (1999).
  CAS PubMed Google Scholar
• Fukumura, D. et al. Tumor induction of VEGF promoter activity in stromal cells. Cell 94, 715–725 (1998).
  Article CAS Google Scholar
• Ausubel, F.M. et al. (eds.) Current Protocols in Molecular Biology (Wiley-Interscience, New York, 1988).
  Google Scholar
• LaVallie, E.R. et al. A thioredoxin gene fusion expression system that circumvents inclusion body formation in the E. coli cytoplasm. Biotechnology (NY) 11, 187–193 (1993).
  CAS Google Scholar
• Bhattacharya, S. et al. Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1. Genes Dev. 13, 64–75 (1999).
  Article CAS Google Scholar